Industry News
Pharmaceutical Industry News
What to Know About Eli Lilly’s Daily Pill for Weight Loss
Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat obesity and diabetes.
Trump Seeks to Lower Drug Prices Through Medicare and Some Imports
President Trump directed his administration to help states import drugs from Canada. But a proposal to alter a Medicare program to reduce costs could wind up raising prices.
Patients Cut Off From Cheaper Obesity Drugs as FDA Halts Sales of Copycats
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or suspend treatment for patients.
S&P 500 and Nasdaq Stocks Post Modest Gains Amid Trump Tariff Uncertainty
The Trump administration’s chaotic tariff rollout continues to spur volatility in the markets.
Trump’s Tariff Threat for Drug imports Poses Big Political Risks
Levies on Americans’ daily prescriptions and other medicines could raise costs, spur rationing and lead to shortages of critical drugs.
Trump Moves to Put New Tariffs on Computer Chips and Drugs
Citing a national security statute, the administration has begun a process to investigate the impact of imported semiconductors and pharmaceuticals.
UK Cuts Tariffs on Dozens of Products as Global Trade Tensions Rise
British officials also announced more financing for exporters as the country sought to protect firms hurt by tariffs.
RFK Jr. Accuses FDA of Drug Industry Influence That Barred Alternative Remedies
The nation’s health secretary addressed agency employees, asking them to shed any corporate influence. But he did not address the mass layoffs that have gutted oversight of tobacco and vapes, food safety and drug reviews.
Una señal de que tu pez podría estar drogado: se arriesga más
Los investigadores que estudian la contaminación farmacéutica rastrearon salmones que habían estado expuestos a ansiolíticos. Los peces parecían perder su inhibición.
Anti-Anxiety Drugs in Water Change Salmon Behavior, Study Finds
Researchers studying pharmaceutical pollution tracked salmon that had been exposed to anti-anxiety medication. The fish appeared to lose their inhibitions.
India’s Drug Makers Shudder as Trump Again Threatens Tariffs
The United States is India’s biggest market for pharmaceutical exports, which are its most successful industrial exports.
Trump Cut H.I.V. Funding. My Patients Are Scared.
There is one tool in our arsenal we must make better use of: PrEP.
Siempre nos quedará el lorazepam
La repentina popularidad del medicamento recetado para la ansiedad es una señal de la obsesión de los fans con Victoria Ratliff, personaje de “The White Lotus”.
After “The White Lotus,” Lorazepam Lives On in Memes and Merch
“The White Lotus” Season 3 may be ending, but the medication that has become synonymous with it has found a new life in memes and merchandise.
Boston Faces Identity Crisis Amid Trump’s Cuts to University and Research Funding
Colleges and teaching hospitals are the cornerstones of the city’s economy — and identity. But federal funding cuts to higher education could change that.
Trump Rejects Proposal for Medicare to Cover Wegovy and Other Obesity Drugs
Administration officials reversed a decision made during the Biden presidency that would have given millions of people access to weight-loss drugs paid for Medicare and Medicaid.
Trump’s Next Tariffs Target Could be Foreign-Made Pharmaceuticals
President Trump wants to bring pharmaceutical manufacturing back to the United States. Experts warn that tariffs could result in shortages and higher prices for generic drugs.
FDA Layoffs Could Raise Drug Costs and Erode Food Safety
Trump cutbacks were supposedly aimed at administrators. But scientists in food and drug-testing labs and policy experts who advance generic drug approvals were also dismissed.
La derecha en EE. UU. sigue defendiendo a la ivermectina
El fármaco se ha convertido en una especie de símbolo de resistencia a lo que algunos en el movimiento MAGA describen como una élite corrupta.
Why the Right Still Embraces Ivermectin
Five years after the pandemic began, interest in the anti-parasitic drug is rising again as right-wing influencers promote it — and spread misinformation about it.